Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma

Area of Science:

• Oncology
• Pulmonary Medicine
• Pathology

Background:

• The lung is a frequent site for cancer metastasis through the bloodstream.
• Tumor emboli lodging in lung vessels can lead to intimal proliferation, a hallmark of pulmonary tumor thrombotic microangiopathy (PTTM).
• PTTM is rarely diagnosed before death.

Observation:

• A case of a 60-year-old woman with metastatic epithelioid angiosarcoma involving the lung is presented.
• Histopathological examination revealed tumor emboli within lung vasculature.
• Tumor cells were found to be positive for Vascular Endothelial Growth Factor (VEGF) and topoisomerase II.

Findings:

• The observed fibrocellular and fibromuscular intimal proliferation is consistent with PTTM.
• VEGF expression in tumor cells may play a role in the development of PTTM.
• Topoisomerase II positivity indicates potential sensitivity to specific therapeutic inhibitors.

Implications:

• This case highlights the importance of considering PTTM in patients with metastatic cancer to the lung.
• VEGF and topoisomerase II may represent therapeutic targets for managing PTTM.
• Early diagnosis and targeted therapies could improve outcomes for patients with this rare condition.